Find-A-Code Focus Newsletter

Product Wastage Documentation Requirements and Reporting- Using JW modifier

December 08, 2016

When using the JW modifier for Part B drug claims for discarded drugs and biologicals, any amount of wasted material should be clearly documented in the medical record with the following information.  

  • Date, time, and location of treatment
  • Approximate amount of product unit used
  • Approximate amount of product unit discarded
  • Reason for the wastage
  • Manufacturer’s serial/lot/batch or other unit identification number

Medicare contractors may also require providers to report discarded amounts of products such as skin substitutes on a separate claim line item by attaching the JW modifier. If reporting Skin grafts or substitutes be sure and report the manufacturer’s serial/lot/batch or other unit identification number of graft material.

Reminder: the JW modifier is required for use on all claims with discarded Part B drugs and biologicals as of Jan 01, 2017. Also, effective January 1, 2017,providers must document the discarded drugs or biologicals in patient's medical record.

Note:

  • The JW modifier is not used on claims for CAP drugs and biologicals.
  • Multi-use vials are not subject to payment for discarded amounts of drug or biological.
  • The JW modifier is only applied to the amount of drug or biological that is discarded.
  • Modifier is billed on a separate line.

References:

share
 

More Items in December 2016


To view more items select a month from our "Items by Month" list.

Or view documentation, coding and billing articles.

 
News Items by Month
February 2022- 1
2021 - View
2020 - View
2019 - View
2018 - View
2017 - View
2016 - View
2015 - View
2014 - View
2013 - View
2012 - View
2011 - View
2010 - View
2009 - View
2008 - View
demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.